최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.32 no.7, 2022년, pp.532 - 541
최윤주 (부산대학교 바이오소재과학과) , 김지은 (부산대학교 바이오소재과학과) , 이수진 (부산대학교 바이오소재과학과) , 공정은 (부산대학교 바이오소재과학과) , 진유정 (부산대학교 바이오소재과학과) , 이재호 (부산대학교 바이오소재과학과) , 임용 (동의대학교 임상병리학과) , 황대연 (부산대학교 바이오소재과학과)
Obesity induced by high-fat diet (HFD) is verified as a strong risk factor and negative prognostic factor for prostate cancer in several genetically engineered mice although it was not examined in the normal mice. To investigate whether HFD-induced obesity can affect the development and progression ...
Bendor, C. D., Bardugo, A., Pinhas-Hamiel, O., Afek, A. and Twig, G. 2020. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity. Cardiovasc. Diabetol. 19, 1-14.
Bhatia-Gaur, R., Donjacour, A. A., Sciavolino, P. J., Kim, M., Desai, N., Young, P., Norton, C. R., Gridley, T., Cardiff, R. D., Cunha, G. R., Abate-Shen, C. and Shen, M. M. 1999. Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 13, 966-977.
Calle, E. E. and Kaaks, R. 2004. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579-591.
Chen, H., Zhou, L., Wu, X., Li, R., Wen, J., Sha, J. and Wen, X. 2016. The PI3K/AKT pathway in the pathogenesis of prostate cancer. Front. Biosci. 21, 1084-1091.
Dan, C., Zhang, H., Zeng, W., Huang, L., Gong, X., Li, H., Yang, E., Wang, L. and Yao, Q. 2019. HNF1B expression regulates ECI2 gene expression, potentially serving a role in prostate cancer progression. Oncol. Lett. 17, 1094-1100.
Discacciati, A., Orsini, N. and Wolk, A. 2014. Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer-a dose-response meta-analysis. Ann. Oncol. 25, 584-591.
Faes, S. and Dormond, O. 2015. PI3K and AKT: unfaithful partners in cancer. Int. J. Mol. Sci. 16, 21138-21152.
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Pineros, M., Znaor, A. and Bray, F. 2021. Cancer statistics for the year 2020: An overview. Int. J. Cancer 149, 778-789.
Fujita, K., Hayashi, T., Matsushita, M., Uemura, M. and Nonomura, N. 2019. Obesity, inflammation, and prostate cancer. J. Clin. Med. 8, 201.
Friedenreich, C. M., McGregor, S. E., Courneya, K. S., Angyalfi, S. J. and Elliott, F. G. 2004. Case-control study of anthropometric measures and prostate cancer risk. Int. J. Cancer 110, 278-283.
Giovannucci, E. and Michaud, D. 2007. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2208-2225.
Hayashi, T., Fujita, K., Nojima, S., Hayashi, Y., Nakano, K., Ishizuya, Y., Wang, C., Yamamoto, Y., Kinouchi, T., Matsuzaki, K., Jingushi, K., Kato, T., Kawashima, A., Nagahara, A., Ujike, T., Uemura, M., Pena, M. D. C. R., Gordetsky, J. B., Morii, E., Tsujikawa, K., Netto, G. J. and Nonomura, N. 2018. High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signaling. Clin. Cancer Res. 54, 4309-4318.
Hu, M. B., Xu, H., Zhu, W. H., Bai, P. D., Hu, J. M., Yang, T., Jiang, H. W. and Ding, Q. 2018. High-fat-diet-induced adipokine and cytokine alterations promote the progression of prostate cancer in vivo and in vitro. Oncol. Lett. 15, 1607-1615.
Huang, M., Koizumi, A., Narita, S., Inoue, T., Tsuchiya, N., Nakanishi, H., Numakura, K., Tsuruta, H., Saito, M., Satoh, S., Nanjo, H., Sasaki, T. and Habuchi, T. 2016. Diet-induced alteration of fatty acid synthase in prostate cancer progression. Oncogenesis 5, e195.
Jung, K. W., Won, Y. J., Hong, S., Kong, H. J. and Lee, E. S. 2020. Prediction of cancer incidence and mortality in korea, 2020. Cancer Res. Treat. 52, 51-358.
Kalender, M. E., Sevinc, A., Tutar, E., Buyukberber, S. and Camci, C. 2007. Metachronous non-hodgkin's lymphoma in a patient with localized prostate cancer. Med. Oncol. 24, 466-468.
Kim, C. W. and Lee, K. H. 2014. Effects of pharmacopuncture on experimental rat model of benign prostatic hyperplasia. J. Acupunct. Res. 31, 95-103.
Knudsen, B. S. and Vasioukhin, V. 2010. Mechanisms of prostate cancer initiation and progression. Adv. Cancer Res. 109, 1-50.
Kojta, I., Chacinska, M. and Blachnio-Zabielska, A. 2020. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients 12, 1305.
Kwan, H. W., Liu, B., Huang, C., Fatima, S., Su, T., Zhao, Z., Ho, A. H. M., Han, Q., Hu, X., Gong, R. H., Chen, M., Wong, H. L. Z. and Bian, Z. 2019. Signal transducer and activator of transcription-3 drives the high-fat diet-associated prostate cancer growth. Cell Death Dis. 10, 637.
Labbe, D. P., Uetani, N., Vinette, V., Lessard, L., Aubry, I., Migon, E., Sirois, J., Haigh, J. J., Begin, L. R., Trotman, L. C., Paquet, M. and Tremblay, M. L. 2016. PTP1B deficiency enables the ability of a high-fat diet to drive the invasive character of PTEN-deficient prostate cancers. Cancer Res. 76, 3130-3135.
Lin, H. P., Lin, C. Y., Liu, C. C., Su, L. C., Huo, C., Kuo, Y. Y., Tseng, J. C., Hsu, J. M., Chen, C. K. and Chuu, C. P. 2013. Caffeic acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling. Int. J. Mol. Sci. 14, 5264-5283.
Liu, S., Zhang, Q., Chen, C., Ge, D., Qu, Y., Chen, R., Fan, Y. M., Li, N., Tang, W. W., Zhang, W., Zhang, K., Wang, A. R., Rowan, B. G., Hill, S. M., Sartor, O., Abdel-Mageed, A. B., Myers, L., Lin, Q. and You, Z. 2016. Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor. Oncotarget 7, 13651.
Narita, S., Nara, T., Sato, H., Koizumi, A., Huang, M., Inoue, T. and Habuchi, T. 2019. Research evidence on high-fat diet-induced prostate cancer development and progression. J. Clin. Med. 8, 597.
Mah, C. Y., Nassar, Z. D., Swinnen, J. V. and Butler, L. M. 2020. Lipogenic effects of androgen signaling in normal and malignant prostate. Asian J. Urol. 7, 258-270.
Manrique-Acevedo, C., Chinnakotla, B., Padilla, J., Martinez-Lemus, L. A. and Gozal, D. 2020. Obesity and cardiovascular disease in women. Int. J. Obes. 44, 1210-1226.
Martini, M., De Santis, M. C., Braccini, L., Gulluni, F. and Hirsch, E. 2014. PI3K/AKT signaling pathway and cancer: an updated review. Ann. Med. 46, 372-383.
Park, J. J., Kim, J. E., Jeon, Y., Lee, M. R., Choi, J. Y., Song, B. R., Park, J. W., Kang, M. J., Choi, H. J., Bae, S. J., Lee, H., Kang, B. C. and Hwang, D. Y. 2020. Deletion of NKX3.1 via CRISPR/Cas9 induces prostatic intraepithelial neoplasia in C57BL/6 mice. Technol. Cancer Res. Treat. 19, 1533033820964425.
Shukla, S., MacLennan, G. T., Hartman, D. J., Fu, P., Resnick, M. I. and Gupta, S. 2007. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int. J. Cancer Res. 121, 1424-1432.
Sivaprakasam, S., Sikder, M. O. F., Ramalingam, L., Kaur, G., Dufour, J. M., Moustaid-Moussa, N., Wachtel, M. S. and Ganapathy, V. 2021. SLC6A14 deficiency is linked to obesity, fatty liver, and metabolic syndrome but only under conditions of a high-fat diet. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 166087.
Venkateswaran, V., Haddad, A. Q., Fleshner, N. E., Fan, R., Sugar, L. M., Nam, R., Klotz, L. H. and Pollak, M. 2007. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J. Natl. Cancer Inst. 99, 1793-1800.
Wang, X., Wei, L., Xiao, J., Shan, K., He, Q., Huang, F., Ge, X., Gao, X., Feng, N. and Chen, Y. Q. 2022. Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer. Neoplasia 24, 86-97.
Wlodarczyk, M. and Nowicka, G. 2019. Obesity, DNA damage, and development of obesity-related diseases. Int. J. Mol. Sci. 20, 1146.
Xu, H., Hu, M. B., Bai, P. D., Zhu, W. H., Liu, S. H., Hou, J. Y., Xiong, Z. Q., Ding, Q. and Jiang, H. W. 2015. Proinflammatory cytokines in prostate cancer development and progression promoted by high-fat diet. Biomed. Res. Int. 2015, 249741.
Yang, T., Wu, X., Hu, J., Hu, M., Xu, H., Jiang, H. and Ding, Q. 2018. Maternal high-fat diet promotes the development and progression of prostate cancer in transgenic adenocarcinoma mouse prostate offspring. Cell Physiol. Biochem. 47, 1862-1870.
Yamamoto, Y., De Velasco, M. A., Kura, Y., Nozawa, M., Hatanaka, Y., Oki, T., Ozeki, T., Shimizu, N., Minami, T., Yoshimura, K., Yoshikawa, K., Nishio, K. and Uemura, H. 2015. Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer. J. Transl. Med. 13, 1-12.
Zaidi, S., Gandhi, J., Seyam, O., Joshi, G., Waltzer, W. C., Smith, N. L. and Khan, S. A. 2018. Etiology, diagnosis, and management of seminal vesicle stones. Curr. Urol. 12, 113-120.
Zhao, Y., Tan, Y. S., Aupperlee, M. D., Langohr, I. M., Kirk, E. L., Troester, M. A., Schwartz, R. C. and Haslam, S. Z. 2013. Pubertal high fat diet: effects on mammary cancer development. Breast Cancer Res. 15, R100.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.